Cytokinetics | CYTK - Pre Tax Profit


Cytokinetics reported $-206.03M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 46.47M 42.49M Jun/2026
Amgen USD 2.08B 570M Mar/2026
Arca Biopharma USD -31.82M 2.24M Mar/2026
Bayer EUR 321M 2.67B Jun/2026
Biogen USD 647.3M 269.6M Jun/2026
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cytokinetics USD -206.03M 23M Mar/2026
Eisai JPY 25.28B 33.22B Jun/2026
Eli Lilly USD 8.85B 583.8M Mar/2026
Exelixis USD 262.68M 5.01M Jun/2026
Geron USD -3.64M 27.5M Mar/2026
Halozyme Therapeutics USD 180.33M 281.18M Mar/2026
Ionis Pharmaceuticals USD -114M 21M Jun/2026
Ligand Pharmaceuticals USD -24.26M 81.04M Mar/2026
Merck USD -3.53B 6.95B Mar/2026
Novartis USD 4.27B 430M Jun/2026
Pfizer USD -653M 5.84B Jun/2026
Regeneron Pharmaceuticals USD 1.53B 696.6M Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
Sanofi EUR 837M 1.17B Jun/2026